• DOI:10.1007/s11739-016-1411-0
Corpus ID: 25807727

Why switch from warfarin to NOACs?

@article{Verdecchia2016WhySF,
  title={Why switch from warfarin to NOACs?},
  author={P. Verdecchia and F. Angeli and Adolfo Aita and C. Bartolini and G. Reboldi},
  journal={Internal and Emergency Medicine},
  year={2016},
  volume={11},
  pages={289-293}
}

P. Verdecchia, F. Angeli, +2 authors G. Reboldi

Published 2016

Medicine

Internal and Emergency Medicine

Several patients with non-valvular atrial fibrillation treated with warfarin or other vitamin-K antagonists (VKA) might benefit from switching to an oral non vitamin-K antagonist anticoagulant (NOAC). In the absence of randomised comparative trials of switching to NOACs versus maintaining VKA treatment, several considerations argue in favour of a switching strategy. First, there is conclusive evidence that haemorrhagic strokes and intracranial bleedings are much fewer in number with NOACs than… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed